Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released May 20, 2022, after the close
10-Q filed May 20, 2022, 50 days after period end · 0001493152-22-014639
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Net Income | -$1.97M | -$597.01K | -$244.64K | -$148.73K |
| EPS Diluted | — | -$0.05 | -$0.03 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2022 · filed May 20, 2022 · 50 d after period end
5.7% from the close of May 16, 2022 to the close of May 23, 2022, the first after the release.